Results for “Drug'S” 9 results

All 9 Health 7 Economy 1 World 1
MS Drug's U.S. Path Tests Medicare's Coverage Speed
Health 04 Aug 2026
MS Drug's U.S. Path Tests Medicare's Coverage Speed
Fampridine's NHS approval renews pressure on CMS to act on nerve-signal therapies
Pancreatic Cancer Pill Reshapes U.S. Oncology Spending Debate
Health 08 Jun 2026
Pancreatic Cancer Pill Reshapes U.S. Oncology Spending Debate
A new pancreatic cancer pill, Daraxonrasib, is reshaping U.S. oncology spending debates, offering a targeted therapy and challeng…
United Kingdom Cannabis Laws: A Complete Breakdown
World 16 May 2026
United Kingdom Cannabis Laws: A Complete Breakdown
Explore the complex cannabis laws in the United Kingdom, examining the ongoing criminalization, regional enforcement variations, …
Type 1 Diabetes Drug Delay Puts U.S. Insurers on Defense
Health 24 Jun 2026
Type 1 Diabetes Drug Delay Puts U.S. Insurers on Defense
European immunotherapy approvals for Type 1 diabetes are prompting U.S. insurers to reassess coverage of preventative treatments …
Weekly Insulin Shot Fuels U.S. Push to Simplify Diabetes Care
Health 20 Aug 2026
Weekly Insulin Shot Fuels U.S. Push to Simplify Diabetes Care
New once-weekly jab could ease burden for millions of Americans managing type 2 diabetes.
Weight-Loss Jabs Reshape U.S. Consumer Spending Patterns
Economy 08 Jul 2026
Weight-Loss Jabs Reshape U.S. Consumer Spending Patterns
GLP-1 drug surge quietly disrupts retail, food, and beverage sectors
FDA's New Weight-Loss Pill Reshapes U.S. Obesity Drug Market
Health 14 Aug 2026
FDA's New Weight-Loss Pill Reshapes U.S. Obesity Drug Market
Eli Lilly's oral GLP-1 entry could pressure insurers and rivals as demand surges
Black Market Retatrutide Floods U.S. as FDA Approval Lags
Health 07 Sep 2026
Black Market Retatrutide Floods U.S. as FDA Approval Lags
Counterfeit weight-loss drugs exploit regulatory gap, raising safety alarms
Weight-Loss Drug Shortage Fuels Counterfeit Crisis Across U.S.
Health 11 Sep 2026
Weight-Loss Drug Shortage Fuels Counterfeit Crisis Across U.S.
Retatrutide fakes flood black market as FDA approval timeline remains unclear
Topics: NHS Policy Ukraine War NHS Net Zero Starmer Zero League Artificial Intelligence Ukraine Senate Russia Champions Champions League Mental Health Renewable Energy Final Bill Grid Block Target Energy Security Council